Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Completed · Phase 2
Conditions studied: Bladder Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chemotherapy in treating patients with early-stage bladder cancer that has not responded to BCG therapy.
Key facts
- Study ID
- NCT00003129
- Run by
- Eastern Cooperative Oncology Group
- People needed
- 75
- Starts
- 1998-09-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2023-06-22
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- Veterans Affairs Medical Center - East Orange — East Orange, New Jersey, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- CCOP - MainLine Health — Wynnewood, Pennsylvania, United States
- CCOP - Green Bay — Green Bay, Wisconsin, United States
- Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
- University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Veterans Affairs Medical Center - Milwaukee (Zablocki) — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.